<

INNATE PHARMA (EPA:IPH) Innate Pharma SA, a biopharmaceutical company developing first-in-class drug candidates targeting the innate immune system, today announces an operating revenue of 12.9 million Euros for the year 2008.

Transparency directive : regulatory news

06/02/2009 17:30

source : webdisclosure.com

INNATE PHARMA's latest news


17/06/2024 07:00
23/05/2024 22:00
05/04/2024 09:34
19/03/2024 07:00
21/02/2024 07:00
03/11/2023 07:00
29/08/2023 07:00
10/08/2023 07:00
10/06/2023 07:00
12/05/2023 22:00


Other stories

31/10/2024 18:50
31/10/2024 21:53
31/10/2024 14:21
31/10/2024 22:47
31/10/2024 18:45
31/10/2024 20:35
31/10/2024 21:37
31/10/2024 15:51
31/10/2024 22:59
31/10/2024 17:31
31/10/2024 22:53
31/10/2024 19:54
31/10/2024 23:06
31/10/2024 14:04
01/11/2024 00:09
31/10/2024 18:49
31/10/2024 12:44
31/10/2024 13:18
31/10/2024 18:58
31/10/2024 18:50
31/10/2024 17:48
31/10/2024 18:08
31/10/2024 15:04
31/10/2024 22:38
31/10/2024 23:58
31/10/2024 11:07
31/10/2024 23:08
31/10/2024 15:44
31/10/2024 18:02
31/10/2024 20:07
31/10/2024 13:43
31/10/2024 12:15
31/10/2024 14:05
30/10/2024 14:09
31/10/2024 20:56
30/10/2024 16:00
31/10/2024 11:44
31/10/2024 21:23